Professional Documents
Culture Documents
BULLECTOMY
• 1992 - VATS
Bullous lung disease
• Expansion of alveolar spaces
• Heavy smoking
• Symptomatic
• Pressure effect – compress normal
functioning lung tissues ,
Pneumothorax
• Asymptomatic – incidental finding
Surgical indications
• Progressive respiratory insufficiency
• Recurring pneumothorax
• persistent pneumothorax
• Hemoptysis
• Chest pain
• Bulla infection
Aims of surgery
• Reduce pressure effect
- Lung Parenchyma
- Diaphragm
- Mediastinum
• Prevent recurrence –
- Pleurodesis
NO BLOOD TRANSFUSION
VATS - WHY
Access procedure
Benefits
•Postop Pain Cellular level
•Postop stay •Cytokine activation
•Acceptance
•Cosmetic •Immune function
•Cost benefit
•Long term benefits
Instrumentation
Author No
Review of literature
O.T Indications Postop Chest Postop Follow
of time Complication drain Hospital up
case (mins) Removal Stay (days) (mths)
s (days)
Akio 16 Dyspnoea(10) Air leak(3-62 36
w.etal Spontaneous days)
pneumothorax(6)
Infection(1)
Teriyashi 50 147.8 Giant bulla(6) 5.2(bulla) 11.3(bulla)
etal (bulla) Spontaneous 1.2(bleb) 4.7(bleb)
45.9 pneumothorax(44)
(bleb)
H.P.Liu 79 70 Symptomatic Subcutaneous 6 9.6 21
etal Bullous emphysema(3)- (4-16) (5-26) (5-37)
(40- emphysema 3.8%
110) Air leak>10
days(7)-8.9%
Localized
empyema(2)
Wound
infection(3)
Gian 29 Spontaneous Reoperation for 5 6 16
franco pneumothorax(23) persistent air (3-14) (3-16) (1-36)
etal Choice(6) leak(2)
Respiratory
failure(2)-6.9%
Tiziano 25 107=25 Complication of Air leak>7 8=4.13 11=5.76
etal bulla(9) days(12)-48%
Dyspnoea(12)
Asymptomatic
giant bulla(4)
Recurrence
• 3 – 10 % overall recurrence in lit
• 23 % with no excision
• Similar recurrence
Thank you